Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.300
-0.060 (-4.41%)
At close: Jun 15, 2026, 4:00 PM EDT
1.294
-0.006 (-0.46%)
After-hours: Jun 15, 2026, 7:38 PM EDT
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $4.53 million as of June 15, 2026. Its market cap has increased by 31.53% in one year.
Market Cap
4.53M
Enterprise Value
-4.92M
1-Year Change
31.53%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since November 14, 2017, Artelo Biosciences's market cap has decreased from $5.88M to $4.53M, a decrease of -22.88%. That is a compound annual growth rate of -2.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 4.53M | 83.98% |
| Dec 31, 2025 | 2.46M | -28.01% |
| Dec 31, 2024 | 3.42M | -23.37% |
| Dec 29, 2023 | 4.46M | -45.90% |
| Dec 30, 2022 | 8.25M | -62.41% |
| Dec 31, 2021 | 21.95M | 99.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 5.11M |
| TransCode Therapeutics | 5.07M |
| FibroBiologics | 5.03M |
| Matinas BioPharma Holdings | 5.00M |
| SciSparc | 4.90M |
| CollPlant Biotechnologies | 4.89M |
| Dermata Therapeutics | 4.75M |
| Alzamend Neuro | 4.60M |